Introduction {#sec1}
============

In recent decades, organofluorine chemistry has been widely developed in the fields of medicine and pesticides.^[@ref1]^ The combination of a fluorine atom or a fluorine-containing compound with a small organic molecule increases the organic molecule's polarity and lipophilicity and alters its biological activity and physicochemical properties.^[@ref2]^ Among fluorine-containing compounds, monofluoroolefins play an important role in organic synthesis, medicinal chemistry, and peptide chemistry.^[@ref3]^ Consequently, a growing number of efficient methodologies for the synthesis of monofluoroalkenes have been reported.^[@ref4]^

In recent years, transition-metal-catalyzed C--H bond activations have been implemented in order to introduce a monofluoroolefin moiety into small organic molecules.^[@ref5]^ Various fluorine-containing reagents, such as *gem*-difluoroalkenes,^[@cit5a]−[@cit5i]^*a*-fluoroacrylic acids,^[@cit5j]^ and *gem*-bromofluoroalkenes,^[@cit5k]^ have been employed as monofluoroolefin synthons. Among these reagents, 2,2-difluorovinyl tosylate has seen broad use in recent years ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref6]^ For example, Li and Wang reported the use of 2,2-difluorovinyl tosylate as a coupling reagent in the Rh(III)-catalyzed C--H activation of the N--X bond of benzamides. This allowed for the assembly of a monofluorinated alkene intermediate with retention of the tosylate functionality, allowing for the preparation of the corresponding fluorinated heterocycles under various conditions ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a,b).^[@cit6a],[@cit6b]^ Li described the Rh(III)-catalyzed α-fluoroalkenylation of *N*-nitrosoanilines with 2,2-difluorovinyl tosylates via C--H bond activation and subsequent β-F elimination to form the desired monofluoroalkene-containing compounds ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}c).^[@cit6c]^

![(a--d) α-Fluoroalkenylation Using Difluoroalkene Tosylates](ao0c01344_0001){#sch1}

The quinazolinone skeleton is present in numerous natural products^[@ref7]^ and has a wide range of applications in medicine and biology.^[@ref8]^ So far, tremendous efforts have been devoted to the development of new synthetic methods for the construction of diverse quinazolinone architectures and the evaluation of their bioactivities.^[@ref9],[@ref10]^ In the past few years, our group has focused extensively on the development of methods for the synthesis of quinazolinone cores and the late-stage functionalization of 2-arylquinazolinones with a desire to construct a quinazolinone-based molecular library for bioactivity assays.^[@ref11]^ Despite progress, there is room for improvement with regard to efficiency and selectivity, especially for the introduction of a monofluoroalkene moiety into the quinazolinone skeleton to form novel monofluoroalkene-quinazolinone derivatives. Monofluoroolefins and the quinazolinone core are important structural motifs in pharmaceuticals and biologically active molecules. Monofluoroolefin-containing quinazolinones may exhibit a wide range of potent applications in the pharmaceutical, agrochemical, and material sciences. Thus, the development of efficient and straightforward protocols to access monofluoroolefin-containing quinazolinones is highly desirable. Thus, we have focused on the preparation of a diverse range of monofluoroolefin-containing quinazolinones ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}d).

Results and Discussion {#sec2}
======================

We initiated our investigation by screening the coupling reaction conditions between 2-(*p*-methylphenyl)quinazolinone **1a** (0.2 mmol) with 2,2-difluorovinyl tosylate **2a** (1.1 equiv) in the presence of RhCp\*(MeCN)~3~(SbF~6~)~2~ (4.0 mol %) and CsOPiv (1.0 equiv). Fortunately, the corresponding monofluoroolefin-quinazolinone compound **3a** was isolated in a yield of 39% when the reaction was conducted in CF~3~CH~2~OH at 60 °C (entry 1). The structure of **3a** was confirmed unambiguously by X-ray crystal diffraction (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01344/suppl_file/ao0c01344_si_001.pdf)). The results of solvent screening indicated that carrying out the reaction in HFIP gave the corresponding product in a high yield of 86% (entries 2--11). The fluorinated solvent HFIP not only have acidic properties but also have H-bonding with the substrate, which can enhance the reaction.^[@ref12]^ Next, the additives, such as Cs~2~CO~3~, CsOAc, CsF, and so forth were examined, and no better result was obtained (entries 12--14). Lower yields were obtained when other catalysts such as IrCp\*Cl~2~/AgSbF~6~ or RhCp\*Cl~2~/AgSbF~6~ were used (entries 15--16). The desired product was obtained in 92% yield when the reaction time was reduced to 6 h (entry 17). Increasing or decreasing the reaction temperature resulted in slightly diminished yields (entries 18--19). Decreasing the loading of CsOPiv gave lower product yields (entries 20--21). Control experiments showed that none of the desired product was obtained in the absence of the RhCp\*(MeCN)~3~(SbF~6~)~2~ catalyst (entry 22) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

###### Optimization of the Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao0c01344_0004){#GRAPHIC-d7e318-autogenerated}

  entry                                                                   catalyst (5 mol %)           solvent            additive   *T* (°C)   yield (%)
  ----------------------------------------------------------------------- ---------------------------- ------------------ ---------- ---------- -----------
  1                                                                       RhCp\*(MeCN)~3~(SbF~6~)~2~   CF~3~CH~2~OH       CsOPiv     60         39
  2                                                                       RhCp\*(MeCN)~3~(SbF~6~)~2~   MeOH               CsOPiv     60         22
  3                                                                       RhCp\*(MeCN)~3~(SbF~6~)~2~   EtOH               CsOPiv     60         19
  4                                                                       RhCp\*(MeCN)~3~(SbF~6~)~2~   1,4-dioxane        CsOPiv     60         trace
  5                                                                       RhCp\*(MeCN)~3~(SbF~6~)~2~   DMF                CsOPiv     60         NR
  6                                                                       RhCp\*(MeCN)~3~(SbF~6~)~2~   DMSO               CsOPiv     60         NR
  7                                                                       RhCp\*(MeCN)~3~(SbF~6~)~2~   THF                CsOPiv     60         trace
  8                                                                       RhCp\*(MeCN)~3~(SbF~6~)~2~   toluene            CsOPiv     60         NR
  9                                                                       RhCp\*(MeCN)~3~(SbF~6~)~2~   benzotrifluoride   CsOPiv     60         NR
  10                                                                      RhCp\*(MeCN)~3~(SbF~6~)~2~   *t*-BuOH           CsOPiv     60         NR
  11                                                                      RhCp\*(MeCN)~3~(SbF~6~)~2~   HFIP               CsOPiv     60         86
  12                                                                      RhCp\*(MeCN)~3~(SbF~6~)~2~   HFIP               CsOAc      60         76
  13                                                                      RhCp\*(MeCN)~3~(SbF~6~)~2~   HFIP               Cs2CO3     60         80
  14                                                                      RhCp\*(MeCN)~3~(SbF~6~)~2~   HFIP               CsF        60         41
  15                                                                      IrCp\*Cl~2~/AgSbF~6~         HFIP               CsOPiv     60         22
  16                                                                      RhCp\*Cl~2~/AgSbF~6~         HFIP               CsOPiv     60         70
  17[b](#t1fn2){ref-type="table-fn"}                                      RhCp\*(MeCN)~3~(SbF~6~)~2~   HFIP               CsOPiv     60         92
  18[b](#t1fn2){ref-type="table-fn"}                                      RhCp\*(MeCN)~3~(SbF~6~)~2~   HFIP               CsOPiv     80         82
  19[b](#t1fn2){ref-type="table-fn"}                                      RhCp\*(MeCN)~3~(SbF~6~)~2~   HFIP               CsOPiv     40         72
  20[b](#t1fn2){ref-type="table-fn"}^,^[c](#t1fn3){ref-type="table-fn"}   RhCp\*(MeCN)~3~(SbF~6~)~2~   HFIP               CsOPiv     60         77
  21[b](#t1fn2){ref-type="table-fn"}                                      RhCp\*(MeCN)~3~(SbF~6~)~2~   HFIP                          60         74
  22[b](#t1fn2){ref-type="table-fn"}                                                                   HFIP               CsOPiv     60         NR

Yields based on isolated.

Time was 6 h.

CsOpiv was added 0.5 equiv.

After establishing the optimized conditions, we investigated the generality and the substrate scope of the reaction. The results are presented in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. As shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, a number of substrates bearing different substituents were amenable to the reaction conditions, giving the corresponding products in good to excellent yields under the optimal conditions. First, the effects of R~1~ on the reaction were explored. The results revealed that the electronic nature and the position of the R~1~ substituent have a significant influence on the reaction. When the substituent R~1~ is at the *para* position of the 2-arylquinazolinone and is an electron-donating group, such as methyl, ethyl, *i*-propyl, methoxy, ethoxy, or an *N,N*-dimethylamino substituent, the desired products are obtained in excellent yields of 83--92% (entries **3a**--**3f**). When R~1~ is at the para position or ortho position of the 2-aryl group and is electron-withdrawing in character (F, Cl, Br, CN, or NO~2~), no reaction occurs (**3h**--**3i**). When the substituent R~1~ is at the ortho position and is an electron-donating group, such as a methyl, methoxy, or ethoxy substituent, the expected products are prepared in good to excellent yields (**3j--3l**). Substrates with an electron-donating R~1~ group at the meta position of the 2-aryl functionality (methyl, methoxy, and ethoxy) were not amenable to the reaction conditions (**3m**--**3n**). However, the desired products were obtained in good yields when an electron-withdrawing R~1~ group is present at this position (**3o**--**3p**).

###### Scope Investigation for the Reaction of 2-Arylquinazolinones **1** and 2,2-Difluorovinyl Tosylate **2**[a](#t2fn1){ref-type="table-fn"}

![](ao0c01344_0005){#GRAPHIC-d7e1072-autogenerated}

![](ao0c01344_0006){#gr4}

Yields based on isolated. Reaction conditions: **1** (0.2 mol), **2** (0.22 mol), RhCp\*(MeCN)~3~(SbF~6~)~2~ (5.0 mol %), CsOPiv (1.0 equiv), HFIP (1.5 mL), 60 °C, 6 h, under air. NR = no reaction.

Subsequently, the effects of the R~2~ group on the quinazolinone ring were explored. Surprisingly, electron-withdrawing and electron-donating groups are tolerated, providing the desired products in excellent yields, no matter what the position of the R~2~ substituent is (entries **3q**--**3za**).

To demonstrate the potential synthetic utility of this reaction, we performed a gram--scale reaction with 2-*p*-methylphenyl-quinazolinone. As shown in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, the product (**3a**) was isolated in a yield of 84%.

![Gram-Scale Reaction](ao0c01344_0002){#sch2}

On the basis of previous reports,^[@ref6]^ a plausible mechanism is described in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. First, an active cation Rh(III) reacts with 2-arylquinazolinone **1** via a key C--H activation to generate the five-membered rhodacycle intermediate **A**, which coordinates with the difluoroolefin to give intermediate **B**. Next, insertion of the difluoroolefin into the C--Rh bond produces a seven-membered Rh(III) complex **C**, which undergoes selective β-F elimination via the *syn*-coplanar state to form the product **3a** and Rh(III).

![Plausible Mechanism for the Reaction of 2-Arylquinazolinones and 2,2-Difluorovinyl Tosylate](ao0c01344_0003){#sch3}

Conclusions {#sec3}
===========

In summary, We have developed an efficient method for the synthesis of 2-(*o*-monofluoroalkenylaryl)quinazolinone derivatives. The reaction of 2-arylquinazolinones and 2,2-difluorovinyl tosylate in the presence of a Rh catalyst produces the corresponding products via C--H bond activation and C--F bond cleavage. The methodology is available to a wide range of substrates, and the presence of a double bond provides the possibility for subsequent research.

Experimental Section {#sec4}
====================

Unless otherwise noted, all reactions were carried out under air atmosphere unless otherwise stated. Commercial reagents were purchased from Aldrich, Alfa, or other commercial suppliers. Commercial reagents were used without further purification. Reactions were conducted using standard techniques on the vacuum line. Analytical thin-layer chromatography (TLC) was performed using glass plates precoated with 0.25 mm 230--400 mesh silica gel impregnated with a fluorescent indicator (254 nm). Flash column chromatography was performed using silica gel (60 °A pore size, 32--63 μm, standard grade). Organic solutions were concentrated on rotary evaporators at 20 Torr (house vacuum) at 25--35 °C. The ^1^H NMR spectra were recorded on a 400 MHz NMR spectrometer. The ^13^C NMR spectra were recorded at 100 MHz. The ^19^F NMR spectra were recorded at 375 MHz. Nuclear magnetic resonance (NMR) spectra are recorded in parts per million (ppm) from internal standard tetramethylsilane (TMS) on the δ scale.

General Procedures for Synthesis of Compound **3** {#sec4.1}
--------------------------------------------------

A mixture of 2-arylquinazolinone **1** (0.2 mmol), 2,2-difluorovinyl tosylate **2** (56.16 mg, 0.24 mmol), RhCp\*(MeCN)~3~(SbF~6~)~2~ (8.33 mg, 5 mol %), and CsOPiv (46.80 mg, 0.2 mmol) in HFIP (1.5 mL) was stirred at 60 °C until **1a** was completed consumed (detected by TLC). Evaporation of the solvent followed purification by column chromatograph over silica gel (normal ratio: petroleum ether/ethyl acetate = 3/1) provided the corresponding product **3**.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-*p*-methylphenyl\]-3*H*-quinazolin-4-one (**3a**) {#sec4.1.1}

The product is obtained as a white solid in 92% yield, 83 mg, mp 205--208 °C, R~*f*~ = 0.45 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.56 (s, 1H), 8.17 (d *J* = 7.2 Hz, 1H), 7.83 (ddd *J* = 8.4, 7.2, 1.2 Hz, 1H), 7.76 (d, *J* = 8.4 Hz, 2H), 7.59--7.53 (m, 2H), 7.48 (d, *J* = 8.0 Hz, 1H), 7.46--7.38 (m, 4H), 6.91 (d, *J* = 20 Hz, 1H), 2.40 (s, 6H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ 162.1, 153.6, 151.1 (d, ^1^*J*~C--F~ = 253.0 Hz), 148.9, 146.5, 140.8, 134.9, 131.7, 131.3, 130.8, 130.5, 129.6 (d, ^3^*J*~C--F~ = 4.0 Hz), 128.2, 127.8, 127.4 (d, ^2^*J*~C--F~ = 22.0 Hz), 127.3, 126.3, 121.5, 121.2 (d, ^2^*J*~C--F~ = 13.0 Hz) 121.1, 21.7, 21.1. ^19^F NMR (376 MHz, DMSO): δ −117.80. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~20~FN~2~O~4~S^+^ \[M + H\]^+^, 451.1122; found, 451.1117.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-*p*-ethylphenyl\]-3*H*-quinazolin-4-one (**3b**) {#sec4.1.2}

The product is obtained as a white solid in 88% yield, 82 mg, mp 166--168 °C, Rf = 0.46 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.54 (s, 1H), 8.18 (d, *J* = 7.8 Hz, 1H), 7.83 (t, *J* = 7.6 Hz, 1H), 7.76 (d, *J* = 8.4 Hz, 2H), 7.59--7.54 (m, 2H), 7.49--7.45 (m, 2H), 7.40 (d, *J* = 8.4 Hz, 2H), 6.94 (d, *J* = 20.0 Hz, 1H), 2.70 (q, *J* = 7.6 Hz, 2H), 2.40 (s, 3H), 1.22 (t, *J* = 7.6 Hz, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.1, 153.6, 151.2 (d, ^1^*J*~C--F~ = 253.1 Hz), 148.9, 146.9, 146.4, 134.9, 131.7, 130.8, 130.7, 130.6, 130.2, 128.6 (d, ^3^*J*~C--F~ = 4.2 Hz), 128.2 127.8, 127.6 (d, ^2^*J*~C--F~ = 21.5 Hz), 127.3, 126.3, 121.5, 121.2 (d, ^2^*J*~C--F~ = 12.5 Hz), 28.3, 21.63, 15.73. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.59. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~25~H~22~FN~2~O~4~S^+^ \[M + H\]^+^, 465.1279; found, 465.1286.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-*p*-i-propylphenyl\]-3*H*-quinazolin-4-one (**3c**) {#sec4.1.3}

The product is obtained as a white solid in 87% yield, 83 mg,, mp 181--183 °C, R~*f*~ = 0.45 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.52 (s, 1H), 8.17 (d, *J* = 7.6 Hz, 1H), 7.83 (t, *J* = 8.0 Hz, 1H), 7.76 (d, *J* = 8.0 Hz, 2H), 7.60 (d, *J* = 8.0 Hz, 1H), 7.56 (t, *J* = 7.6 Hz, 1H), 7.51--7.45 (m, 3H), 7.40 (d, *J* = 8.0 Hz, 2H), 6.96 (d, *J* = 20.0 Hz, 1H), 3.00 (m, *J* = 6.8 Hz, 1H), 2.40 (s, 3H), 1.25 (d, *J* = 6.8 Hz, 6H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ 162.0, 153.6, 151.4, 151.2 (d, ^1^*J*~C--F~ = 254.0 Hz), 148.9, 146.4, 134. 9, 131.7, 131.1, 130.7, 130.6, 128.7, 128.2, 127.8, 127.6 (d, ^2^*J*~C--F~ = 22.0 Hz), 127.3 (d, ^3^*J*~C--F~ = 4.0 Hz), 126.3, 121.5, 121.3 (d, ^2^*J*~C--F~ = 13.0 Hz), 33.7, 23.9, 21.7. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.35. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~24~FN~2~O~4~S^+^ \[M + H\]^+^, 479.1435; found, 479.1449.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-*p*-methyloxylphenyl\]-3*H*-quinazolin-4-one (**3d**) {#sec4.1.4}

The product is obtained as a white solid in 84% yield, 81 mg,, mp 165--168 °C, R~*f*~ = 0.40 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.52 (s, 1H), 8.17 (d, *J* = 8.0 Hz, 1H), 7.83 (d, *J* = 8.0 Hz, 1H), 7.78 (d, *J* = 8.0 Hz, 2H), 7.63 (d, *J* = 8.8 Hz, 1H), 7.54 (t, *J* = 7.6 Hz, 1H), 7.45 (d, *J* = 7.6 Hz, 1H), 7.42 (d, *J* = 8.0 Hz, 2H), 7.17 (dd, *J* = 8.8, 2.4 Hz, 1H), 7.12 (s, 1H), 7.00 (d, *J* = 19.6 Hz, 1H), 3.87 (s, 3H), 2.40 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.2, 160.7, 153.4, 150.9 (d, ^1^*J*~C--F~ = 254.0 Hz), 149.0, 146.5, 134.8, 132.3, 131.7, 130.8, 129.2 (d, ^2^*J*~C--F~ = 22.0 Hz), 128.3, 127.7, 127.1, 126.2, 125.6, 121.6 (d, ^2^*J*~C--F~ = 12.0 Hz), 121.4, 116.1, 114.8 (d, ^3^*J*~C--F~ = 4.0 Hz), 56.2, 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.57. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~20~FN~2~O~5~S^+^ \[M + H\]^+^, 467.1072; found, 467.1077.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-*p*-ethyloxylphenyl\]-3*H*-quinazolin-4-one (**3e**) {#sec4.1.5}

The product is obtained as a white solid in 83% yield, 77 mg,, mp 178--180 °C, R~*f*~ = 0.40 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.50 (s, 1H), 8.17 (d, *J* = 7.6 Hz, 1H), 7.82 (d, *J* = 7.2 Hz, 1H), 7.78 (d, *J* = 8.4 Hz, 2H), 7.60 (d, *J* = 8.4 Hz, 1H), 7.54 (t, *J* = 7.6 Hz, 1H), 7.45 (d, *J* = 8.0 Hz, 1H), 7.41 (d, *J* = 8.0 Hz, 2H), 7.15 (d, *J* = 8.4 Hz, 1H), 7.10 (s, 1H), 7.00 (d, *J* = 19.6 Hz, 1H), 4.15 (q, *J* = 6.8 Hz, 2H), 2.40 (s, 3H), 1.36 (t, *J* = 6.8 Hz, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.2, 160.0, 153.4, 150.9 (d, ^1^*J*~C--F~ = 253.0 Hz), 149.0, 146.4, 134.8, 132.3, 131.7, 130.8, 129.2 (d, ^2^*J*~C--F~ = 22.0 Hz), 128.3, 127.7, 127.1, 126.2, 125.5, 121.5 (d, ^2^*J*~C--F~ = 12.0 Hz), 121.4, 116.4, 115.2 (d, ^3^*J*~C--F~ = 5.0 Hz), 64.2, 21.6, 14.9. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.60. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~25~H~22~FN~2~O~5~S^+^ \[M + H\]^+^, 481.1228; found, 481.1223.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-*p*-*N*,*N*-dimethylaminophenyl\]-3*H*-quinazolin-4-one (**3f**) {#sec4.1.6}

The product is obtained as a white solid in 83% yield, 80 mg,, mp 199--201 °C, R~*f*~ = 0.44 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.34 (s, 1H), 8.12 (d, *J* = 8.0 Hz, 1H), 7.82 (*J* = 7.6 Hz, 2H), 7.77 (ddd, *J* = 8.4, 7.2, 1.2 Hz, 1H), 7.53 (*J* = 8.4 Hz, 1H), 7.49 (t, *J* = 8.0 Hz, 1H), 7.43 (d, *J* = 8.4 Hz, 2H), 7.36 (d, *J* = 8.0 Hz, 1H), 6.91 (d, *J* = 19.6 Hz, 1H), 6.84 (dd, *J* = 8.8, 2.4 Hz, 1H), 6.70 (s, 1H), 3.00 (s, 6H), 2.40 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.5, 153.6, 152.4 (d, ^1^*J*~C--F~ = 254.0 Hz), 151.4, 149.2, 146.4, 134.7, 131.8, 131.6, 130.7, 128.8 (d, ^2^*J*~C--F~ = 21.0 Hz), 128.3, 127.5, 126.7, 126.2, 121.1, 120.7 (d, ^2^*J*~C--F~ = 12.0 Hz), 119.9, 113.1, 112.8 (d, ^3^*J*~C--F~ = 4.0 Hz), 40.2, 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −114.81. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~25~H~23~FN~3~O~4~S^+^ \[M + H\]^+^, 480.1388; found, 480.1398.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-phenyl\]-3*H*-quinazolin-4-one (**3g**) {#sec4.1.7}

The product is obtained as a white solid in 83% yield, 73 mg,, mp 188--190 °C, R~*f*~ = 0.48 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.62 (s, 1H), 8.21 (d, *J* = 7.6 Hz, 1H), 7.86 (t, *J* = 7.6 Hz, 1H), 7.76 (d, *J* = 8.0 Hz, 2H), 7.78--7.51 (m, 6H), 7.41 (d, *J* = 8.0 Hz, 2H), 6.94 (d, *J* = 19.6 Hz, 1H), 2.41 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.0, 153.6, 150.9 (d, ^1^*J*~C--F~ = 253.0 Hz), 148.9, 146.5, 134.9, 133.3, 131.64, 130.9, 130.9, 130.8, 130.6, 129.2 (d, ^3^*J*~C--F~ = 4.0 Hz), 128.2, 127.8, 127.6, 127.4 (d, ^3^*J*~C--F~ = 3.0 Hz), 126.3, 121.6, 121.4 (d, *J* = 13.0 Hz), 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.96. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~23~H~20~FN2O~4~S^+^ \[M + H\]^+^, 437.0966; found, 437.0975.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-6-methylphenyl\]-3*H*-quinazolin-4-one (**3j**) {#sec4.1.8}

The product is obtained as a white solid in 35% yield, 31 mg, mp 146--148 °C, R~*f*~ = 0.51 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.54 (s, 1H), 8.20 (d, *J* = 6.8 Hz, 1H), 7.88 (ddd, *J* = 7.6, 7.2, 1.6 Hz, 1H), 7.65--7.58 (m, 4H), 7.51--7.43 (m, 3H), 7.34 (d, *J* = 8.4 Hz, 2H), 6.77 (d, *J* = 19.6 Hz, 1H), 2.39 (s, 3H), 2.18 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.8, 153.2, 150.7 (d, ^1^*J*~C--F~ = 253.0 Hz), 148.9, 146.4, 137.6, 135.0, 132.9, 132.8, 131.5, 130.7, 130.2, 128.0, 127.9, 127.5, 127.3, 126.4, 126.0 (d, ^3^*J*~C--F~ = 5.0 Hz), 121.5 (d, ^2^*J*~C--F~ = 17.0 Hz), 121.3, 21.7, 19.4. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −118.22. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~20~FN~2~O~4~S^+^ \[M + H\]^+^, 451.1122; found, 451.1225.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-6-methyloxylphenyl\]-3*H*-quinazolin-4-one (**3k**) {#sec4.1.9}

The product is obtained as a white solid in 87% yield, 81 mg, mp 178--180 °C, R~*f*~ = 0.50 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.46 (s, 1H), 8.20 (d, *J* = 7.6 Hz, 1H), 7.86 (t, *J* = 7.6 Hz, 1H), 7.66--7.51 (m, 5H), 7.34 (d, *J* = 8.0 Hz, 2H), 7.30 (d, *J* = 8.4 Hz, 1H), 7.20 (d, *J* = 8.0 Hz, 1H), 6.86 (d, *J* = 20.0 Hz, 1H), 3.78 (s, 3H), 2.38 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.8, 158.0, 151.4, 150.3 (d, ^1^*J*~C--F~ = 254.0 Hz), 149.1, 146.5, 134.9, 131.8, 131.5, 130.7, 128.6 (d, ^2^*J*~C--F~ = 22.0 Hz), 128.0, 127.8, 127.4, 126.3, 122.4, 121.7, 121.6 (d, ^2^*J*~C--F~ = 13.0 Hz), 120.2 (d, ^3^*J*~C--F~ = 5.0 Hz), 114.3, 56.6, 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −118.87. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~20~FN~2~O~5~S^+^ \[M + H\]^+^, 467.1072; found, 467.1077.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-6-ethyloxylphenyl\]-3*H*-quinazolin-4-one (**3l**) {#sec4.1.10}

The product is obtained as a white solid in 86% yield, 83 mg, mp 151--153 °C, R~*f*~ = 0.48 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.45 (s, 1H), 8.21 (d, *J* = 7.6 Hz, 1H), 7.85 (t, *J* = 7.6 Hz, 1H), 7.64 (d, *J* = 8.4 Hz, 2H), 7.62--7.49 (m, 3H), 7.35 (d, *J* = 8.4 Hz, 2H), 7.28 (d, *J* = 8.4 Hz, 1H), 7.19 (d, *J* = 7.6 Hz, 1H), 6.88 (d, *J* = 20.0 Hz, 1H), 4.07 (q, *J* = 7.0 Hz, 2H), 2.38 (s, 3H), 1.16 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.8, 157.4, 151.5, 150.4 (d, ^1^*J*~C--F~ = 253.0 Hz), 149.2, 146.4, 134.8, 131.8, 131.5, 130.7, 128.6 (d, ^2^*J*~C--F~ = 22.0 Hz), 128.1, 127.8, 127.3, 126.3, 122.7, 121.7, 121.5 (d, ^2^*J*~C--F~ = 13.0 Hz), 120.2 (d, ^3^*J*~C--F~ = 5.0 Hz), 115.4, 64.9, 21.6, 14.8. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −118.71. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~25~H~22~FN~2~O~5~S^+^ \[M + H\]^+^, 481.1228; found, 481.1230.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-5-methylphenyl\]-3*H*-quinazolin-4-one (**3m**) {#sec4.1.11}

The product is obtained as a white solid in 30% yield, 27 mg, mp 168--170 °C, R~*f*~ = 0.53 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.53 (s, 1H), 8.18 (dd, *J* = 8.0, 1.2 Hz, 1H), 7.85 (ddd, *J* = 8.4, 6.8, 1.6 Hz, 1H), 7.73 (d, *J* = 8.4 Hz, 2H), 7.57 (ddd, *J* = 8.0, 6.8, 1.2 Hz, 1H), 7.53--7.48 (m, 3H), 7.34 (s, 1H), 7.39 (d, *J* = 8.4 Hz, 1H), 6.83 (d, *J* = 20.0 Hz, 1H), 2.40 (s, 6H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.0, 153.7, 151.0 (d, ^1^*J*~C--F~ = 253.0 Hz), 148.9, 146.4, 140.9, 1350.0, 133.2, 131.7, 131.2, 131.1, 130.7, 129.1 (d, ^3^*J* = 3.0 Hz), 128.2, 127.8, 127.3, 126.3, 124.7 (d, ^2^*J*~C--F~ = 22.0 Hz), 121.5, 120.9 (d, ^2^*J*~C--F~ = 13.0 Hz), 21.7, 21.2. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.45. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~20~FN~2~O~4~S^+^ \[M + H\]^+^, 451.1122; found, 451.1120.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-5-chlorophenyl\]-3*H*-quinazolin-4-one (**3o**) {#sec4.1.12}

The product is obtained as a pale yellow solid in 65% yield, 61 mg, mp 187--189 °C, R~*f*~ = 0.55 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.63 (s, 1H), 8.19 (d, *J* = 8.0 Hz, 1H), 7.85 (t, *J* = 7.6 Hz, 1H), 7.81 (d, *J* = 7.6 Hz, 1H), 7.74 (d, *J* = 8.0 Hz, 2H), 7.71--7.63 (m, 2H), 7.58 (t, *J* = 7.6 Hz, 1H), 7.52 (d, *J* = 8.0 Hz, 1H), 7.40 (d, *J* = 8.0 Hz, 2H), 6.98 (d, *J* = 19.6 Hz, 1H), 2.40 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.9, 152.3, 149.9 (d, ^1^*J*~C--F~ = 253.0 Hz), 148.7, 146.5, 135.4, 135.0, 134.8, 131.6, 130.9 (d, ^3^*J*~C--F~ = 5.0 Hz), 130.8, 130.6 (d, ^2^*J*~C--F~ = 13.0 Hz), 128.2, 128.1 (d, ^3^*J*~C--F~ = 6.0 Hz), 127.9, 127.6, 126.5, 126.3, 121.9 (d, ^2^*J*~C--F~ = 12.0 Hz), 121.7, 21.7. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −118.90. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~23~H~17~ClFN~2~O~4~S^+^ \[M + H\]^+^, 471.0576; found, 471.0573.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-5-fluorophenyl\]-3*H*-quinazolin-4-one (**3p**) {#sec4.1.13}

The product is obtained as a pale yellow solid in 65% yield, 59 mg, mp 191--192 °C, R~*f*~ = 0.54 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.65 (s, 1H), 8.20 (dd, *J* = 8.0, 1.2 Hz, 1H), 7.86 (ddd, *J* = 8.4, 6.8, 1.2 Hz, 1H), 7.75 (d, *J* = 8.4 Hz, 2H), 7.72--7.57 (m, 3H), 7.53--7.47 (m, 2H), 7.41 (d, *J* = 8.0 Hz, 2H), 6.94 (d, *J* = 19.6 Hz, 1H), 2.41 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.9 (d, ^1^*J*~C--F~ = 248.0 Hz), 161.9, 152.3, 150.1 (d, ^1^*J*~C--F~ = 254.0 Hz), 148.7, 146.5, 135.6 (d, ^3^*J*~C--F~ = 8.0 Hz), 135.0, 132.0 (dd, ^33^*J* = 8.0, 4.0 Hz), 131.6, 130.8, 128.2, 127.8, 127.6, 126.3, 124.2 (dd, ^24^*J*~C--F~ = 23.0, 3.0 Hz), 121.6, 121.4 (d, ^2^*J*~C--F~ = 13.0 Hz), 118.0 (d, ^2^*J*~C--F~ = 18.0 Hz), 117.8 (d, ^2^*J*~C--F~ = 16.0 Hz), 21.7. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −109.37, −117.14. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~23~H~17~F~2~N~2~O~4~S^+^ \[M + H\]^+^, 455.0872; found, 455.0879.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-phenyl\]-6-methyloxyl-3*H*-quinazolin-4-one (**3q**) {#sec4.1.14}

The product is obtained as a white solid, 82 mg, 88% yield, mp 209--210 °C, R~*f*~ = 0.40 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.54 (s, 1H), 7.75 (d, *J* = 8.0 Hz, 2H), 7.68--7.55 (m, 5H), 7.50--7.36 (m, 4H), 6.88 (d, *J* = 19.6 Hz, 1H), 3.91 (s, 3H), 2.39 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.8, 158.5, 151.2, 152.0 (d, ^1^*J*~C--F~ = 254.0 Hz), 146.4, 143.4, 133.4, 131.6, 130.8, 130.7, 130.6 (d, ^3^*J*~C--F~ = 5.0 Hz), 129.5, 129.2 (d, ^3^*J*~C--F~ = 5.0 Hz), 128.2, 127.5 (d, ^2^*J*~C--F~ = 22.0 Hz), 124.3, 122.4, 121.3 (d, ^2^*J*~C--F~ = 12.0 Hz), 106.4, 56.2, 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.94. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~20~FN~2~O~5~S^+^ \[M + H\]^+^, 467.1072; found, 467.1077.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-4-methylphenyl\]-6-methyloxyl-3*H*-quinazolin-4-one (**3r**) {#sec4.1.15}

The product is obtained as a white solid, 1 mg, 86% yield, mp 205--207 °C, R~*f*~ = 0.41 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.49 (s, 1H), 7.76 (d, *J* = 8.4 Hz, 2H), 7.58--7.51 (m, 2H), 7.46--7.37 (m, 6H), 6.87 (d, *J* = 19.6 Hz, 1H), 3.91 (s, 3H), 2.39 (s, 6H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.9, 158.4, 151.3, 151.1 (d, ^1^*J*~C--F~ = 254.0 Hz), 146.4, 143.4, 140.6, 131.7, 131.3, 130.8, 130.7, 130.5, 129.6 (d, ^3^*J*~C--F~ = 4.0 Hz), 129.5, 128.2, 127.4 (d, ^2^*J*~C--F~ = 22.0 Hz), 124.3, 122.3, 121.2 (d, ^2^*J*~C--F~ = 13.0 Hz), 106.4, 56.2, 21.6, 21.1. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.76. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~25~H~22~FN~2~O~5~S^+^ \[M + H\]^+^, 481.1228; found, 481.1232.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-4-methyloxylphenyl\]-6-methyloxyl-3*H*-quinazolin-4-one (**3s**) {#sec4.1.16}

The product is obtained as a white solid, 85 mg, 86% yield, mp 201--202 °C, R~*f*~ = 0.42 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.44 (s, 1H), 7.75 (d, *J* = 8.0 Hz, 2H), 7.58 (d, *J* = 8.8 Hz, 1H), 7.55 (s, 1H), 7.46--7.36 (m, 4H), 7.15 (dd, *J* = 8.8, 2.4 Hz, 1H), 7.08 (d, *J* = 2.4 Hz, 1H), 6.92 (d, *J* = 19.6 Hz, 1H), 3.90 (s, 3H), 3.86 (s, 3H), 2.39 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.0, 160.6, 158.3, 151.1, 150.9 (d, ^1^*J*~C--F~ = 253.0 Hz), 146.5, 143.5, 132.2, 131.6, 130.8, 129.4, 129.1 (d, ^2^*J*~C--F~ = 22.0 Hz), 128.2, 125.7, 124.3, 122.2, 121.5 (d, ^2^*J*~C--F~ = 12.0 Hz), 116.1, 114.7 (d, ^3^*J*~C--F~ = 5.0 Hz), 106.3, 56.2, 56.1, 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.63. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~25~H~22~FN~2~O~6~S^+^ \[M + H\]^+^, 497.1177; found, 497.1180.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-phenyl\]-6-chloro-3*H*-quinazolin-4-one (**3t**) {#sec4.1.17}

The product is obtained as a white solid, 82 mg, 87% yield, mp 219--220 °C, R~*f*~ = 0.42 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.80 (s, 1H), 8.11 (d, *J* = 2.4 Hz, 1H), 7.86 (dd, *J* = 8.8, 2.4 Hz, 1H), 7.76 (d, *J* = 8.0 Hz, 2H), 7.71--7.60 (m, 4H), 7.54 (d, *J* = 8.8 Hz, 1H), 7.41 (d, *J* = 8.4 Hz, 2H), 6.90 (d, *J* = 19.6 Hz, 1H), 2.40 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.1, 154.2, 150.8 (d, ^1^*J*~C--F~ = 254.0 Hz), 147.6, 146.5, 135.1, 133.0, 131.7, 131.6, 130.9, 130.8, 130.7, 130.6, 130.0, 129.2 (d, ^3^*J*~C--F~ = 4.0 Hz), 128.2, 127.5 (d, ^2^*J*~C--F~ = 22.0 Hz), 125.3, 122.8, 121.4 (d, ^2^*J*~C--F~ = 13.0 Hz), 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.92. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~23~H~17~ClFN~2~O~4~S^+^ \[M + H\]^+^, 471.0576; found, 471.0583.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-4-methylphenyl\]-6-chloro-3*H*-quinazolin-4-one (**3u**) {#sec4.1.18}

The product is obtained as a white solid, 83 mg, 86% yield, mp 200--201 °C, R~*f*~ = 0.39 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.73 (s, 1H), 8.09 (d, *J* = 2.4 Hz, 1H), 7.85 (dd, *J* = 8.8, 2.4 Hz, 1H), 7.75 (d, *J* = 8.4 Hz, 2H), 7.54 (d, *J* = 8.4 Hz, 1H), 7.51 (d, *J* = 8.4 Hz, 1H), 7.44--7.40 (m, 4H), 6.85 (d, *J* = 19.6 Hz, 1H), 2.40 (s, 6H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.2, 154.1, 151 (d, ^1^*J*~C--F~ = 253.0 Hz), 147.6, 146.5, 141.0, 135.1, 131.6, 131.6, 131.4, 130.8, 130.5, 130.2, 130.0, 129.6, 128.2, 127.4 (d, ^2^*J*~C--F~ = 21.0 Hz), 125.3, 122.6, 121.2 (d, ^2^*J*~C--F~ = 12.0 Hz), 21.6, 21.1. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.71. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~19~ClFN~2~O~4~S^+^ \[M + H\]^+^, 485.0733; found, 485.0743.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-4-methyloxylphenyl\]-6-chloro-3*H*-quinazolin-4-one (**3v**) {#sec4.1.19}

The product is obtained as a white solid, 83 mg, 83% yield, mp 181--183 °C, R~*f*~ = 0.40 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.70 (s, 1H), 8.08 (d, *J* = 2.0 Hz, 1H), 7.83 (dd, *J* = 8.4, 2.4 Hz, 1H), 7.79 (d, *J* = 8.0 Hz, 2H), 7.62 (d, *J* = 8.8 Hz, 1H), 7.46 (d, *J* = 8.8 Hz, 1H), 7.43 (d, *J* = 8.4 Hz, 2H), 7.17 (dd, *J* = 8.4, 2.0 Hz, 1H), 7.12 (s, 1H), 6.98 (d, *J* = 19.6 Hz, 1H), 3.87 (s, 3H), 2.41 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.3, 160.9, 153.9, 150.7 (d, ^1^*J*~C--F~ = 253.0 Hz), 147.5, 146.5, 135.0, 132.3, 131.6, 131.5, 130.7, 129.8, 129.2 (d, ^2^*J*~C--F~ = 22.0 Hz), 128.2, 125.3, 125.2, 122.5, 121.5 (d, ^2^*J*~C--F~ = 12.0 Hz), 116.1, 114.8 (d, ^3^*J*~C--F~ = 4.0 Hz), 56.2, 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.45. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~19~ClFN~2~O~5~S^+^ \[M + H\]^+^, 501.0682; found, 501.0672.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-phenyl\]-6-bromo-3*H*-quinazolin-4-one (**3w**) {#sec4.1.20}

82 mg, 80% yield, white solid, mp 217--219 °C, R~*f*~ = 0.39 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.80 (s, 1H), 8.26 (d, *J* = 2.4 Hz, 1H), 8.00 (dd, *J* = 8.8, 2.4 Hz, 1H), 7.76 (d, *J* = 8.0 Hz, 2H), 7.70--7.60 (m, 4H), 7.47 (d, *J* = 8.8 Hz, 1H), 7.42 (d, *J* = 8.4 Hz, 2H), 6.90 (d, *J* = 19.6 Hz, 1H), 2.41 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 160.9, 154.2, 150.8 (d, ^1^*J*~C--F~ = 254.0 Hz), 147.9, 146.5, 137.8, 133.0, 131.6, 130.9, 130.8, 130.7, 130.5, 130.2, 129.2 (d, ^3^*J* = 4.0 Hz), 128.4, 128.2, 127.5 (d, ^2^*J*~C--F~ = 22.0 Hz), 123.1, 121.4 (d, ^2^*J*~C--F~ = 12.0 Hz), 119.8, 21.7. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.91. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~23~H~17~BrFN~2~O~4~S^+^ \[M + H\]^+^, 515.0071; found, 515.0076.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-4-methylphenyl\]-6-bromo-3*H*-quinazolin-4-one (**3x**) {#sec4.1.21}

The product is obtained as a white solid, 85 mg, 80% yield, mp 195--197 °C, R~*f*~ = 0.40 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.74 (s, 1H), 8.23 (s, 1H), 7.97 (dd, *J* = 8.4, 2.4 Hz, 1H), 7.80--7.66 (m, 2H), 7.56 (d, *J* = 7.6 Hz, 1H), 7.43 (dd, *J* = 10.0, 3.7 Hz, 5H), 6.88 (d, *J* = 19.6 Hz, 1H), 2.40 (s, 6H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.0, 154.2, 151.0 (d, ^1^*J*~C--F~ = 254.0 Hz), 147.9, 146.4, 141.0, 137.8, 131.7, 131.3, 130.7, 130.5, 130.3, 130.1, 129.6 (d, ^3^*J* = 4.0 Hz), 128.4, 128.2, 127.4 (d, ^2^*J*~C--F~ = 22.0 Hz), 123.0, 121.2 (d, ^2^*J*~C--F~ = 13.0 Hz), 119.7, 21.6, 21.1. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.69. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~19~BrFN~2~O~4~S^+^ \[M + H\]^+^, 529.0228; found, 529.0233.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-phenyl\]-7-methyl-3*H*-quinazolin-4-one (**3y**) {#sec4.1.22}

The product is obtained as a white solid, 77 mg, 85% yield, mp 212--213 °C, R~*f*~ = 0.41 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.51 (s, 1H), 8.08 (d, *J* = 8.4 Hz, 1H), 7.75 (d, *J* = 8.0 Hz, 2H), 7.70--7.56 (m, 4H), 7.39--7.37 (m, 4H), 6.91 (d, *J* = 19.6 Hz, 1H), 2.47 (s, 3H), 2.37 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 161.9, 153.7, 150.9 (d, ^1^*J*~C--F~ = 254.0 Hz), 149.1, 146.4, 145.5, 133.4, 131.6, 130.9, 130.7, 130.5, 129.1 (d, ^3^*J*~C--F~ = 5.0 Hz), 128.8, 128.2, 127.5 (d, ^2^*J*~C--F~ = 21.0 Hz), 127.4, 126.2, 121.4 (d, ^2^*J*~C--F~ = 13.0 Hz), 119.2, 21.8, 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.98. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~20~FN~2~O~4~S^+^ \[M + H\]^+^, 451.1122; found, 451.1119.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-4-methylphenyl\]-7-methyl-3*H*-quinazolin-4-one (**3z**) {#sec4.1.23}

The product is obtained as a white solid, 79 mg, 85% yield, mp 204--206 °C, R~*f*~ = 0.39 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.46 (s, 1H), 8.06 (d, *J* = 8.0 Hz, 1H), 7.76 (d, *J* = 8.0 Hz, 2H), 7.53 (d, *J* = 7.6 Hz, 1H), 7.45--7.33 (m, 6H), 6.89 (d, *J* = 19.6 Hz, 1H), 2.46 (s, 3H), 2.39 (d, *J* = 6.8 Hz, 6H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.0, 153.7, 151.1 (d, ^1^*J*~C--F~ = 254.0 Hz), 149.0, 146.4, 145.5, 140.7, 131.7, 131.3, 130.7, 130.6, 130.5, 129.5 (d, ^3^*J*~C--F~ = 5.0 Hz), 128.7, 128.2, 127.4 (d, ^2^*J* = 21.0 Hz), 127.3, 126.2, 121.2 (d, ^2^*J*~C--F~ = 13.0 Hz), 119.1, 21.8, 21.6, 21.1. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.83. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~25~H~22~FN~2~O~4~S^+^ \[M + H\]^+^, 465.1279; found, 465.1286.

### 2-\[2-(1-Fluoro-2-*p*-methylbenzenesulfonyloxyl-vinyl)-4-methyloxylphenyl\]-7-methyl-3*H*-quinazolin-4-one (**3za**) {#sec4.1.24}

The product is obtained as a white solid, 80 mg, 83% yield, mp 196--198 °C, R~*f*~ = 0.39 (petroleum ether/ethyl acetate = 2/1). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 12.40 (s, 1H), 8.05 (d, *J* = 8.0 Hz, 1H), 7.78 (d, *J* = 8.0 Hz, 2H), 7.60 (d, *J* = 8.4 Hz, 1H), 7.44--7.29 (m, 4H), 7.16 (dd, *J* = 8.4, 2.0 Hz, 1H), 7.10 (s, 1H), 6.98 (d, *J* = 19.6 Hz, 1H), 3.87 (s, 3H), 2.46 (s, 3H), 2.38 (s, 3H). ^13^C NMR (101 MHz, DMSO-*d*~6~): δ 162.1, 160.7, 153.5, 150.8 (d, ^1^*J*~C--F~ = 254.0 Hz), 149.2, 146.4, 145.4, 132.2, 131.7, 130.7, 129.1 (d, ^2^*J*~C--F~ = 22.0 Hz), 128.6, 128.2, 127.3, 126.1, 125.8, 121.5 (d, ^2^*J*~C--F~ = 12.0 Hz), 119.0, 116.1, 114.7 (d, ^3^*J*~C--F~ = 5.0 Hz), 56.2, 21.8, 21.6. ^19^F NMR (376 MHz, DMSO-*d*~6~): δ −117.64. HRMS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~25~H~22~FN~2~O~5~S^+^ \[M + H\]^+^, 481.1228; found, 481.1232.
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